1. Home
  2. RGEN vs MIDD Comparison

RGEN vs MIDD Comparison

Compare RGEN & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MIDD
  • Stock Information
  • Founded
  • RGEN 1981
  • MIDD 1888
  • Country
  • RGEN United States
  • MIDD United States
  • Employees
  • RGEN N/A
  • MIDD N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MIDD Industrial Machinery/Components
  • Sector
  • RGEN Health Care
  • MIDD Industrials
  • Exchange
  • RGEN Nasdaq
  • MIDD Nasdaq
  • Market Cap
  • RGEN 8.0B
  • MIDD 7.0B
  • IPO Year
  • RGEN N/A
  • MIDD N/A
  • Fundamental
  • Price
  • RGEN $126.50
  • MIDD $151.49
  • Analyst Decision
  • RGEN Buy
  • MIDD Buy
  • Analyst Count
  • RGEN 12
  • MIDD 8
  • Target Price
  • RGEN $172.67
  • MIDD $171.14
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • MIDD 980.8K
  • Earning Date
  • RGEN 04-29-2025
  • MIDD 05-07-2025
  • Dividend Yield
  • RGEN N/A
  • MIDD N/A
  • EPS Growth
  • RGEN N/A
  • MIDD 11.43
  • EPS
  • RGEN N/A
  • MIDD 8.00
  • Revenue
  • RGEN $650,429,000.00
  • MIDD $3,854,863,000.00
  • Revenue This Year
  • RGEN $13.93
  • MIDD $3.87
  • Revenue Next Year
  • RGEN $14.35
  • MIDD $3.88
  • P/E Ratio
  • RGEN N/A
  • MIDD $18.90
  • Revenue Growth
  • RGEN 4.88
  • MIDD N/A
  • 52 Week Low
  • RGEN $102.97
  • MIDD $118.41
  • 52 Week High
  • RGEN $182.52
  • MIDD $182.73
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • MIDD 64.44
  • Support Level
  • RGEN $123.10
  • MIDD $130.90
  • Resistance Level
  • RGEN $135.47
  • MIDD $150.00
  • Average True Range (ATR)
  • RGEN 6.98
  • MIDD 3.93
  • MACD
  • RGEN -0.97
  • MIDD 2.62
  • Stochastic Oscillator
  • RGEN 25.20
  • MIDD 99.18

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

Share on Social Networks: